Nachrichten zur Heron Therapeutics Inc. Aktie

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery

SAN DIEGO , Jan. 21, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a…

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program

SAN DIEGO , Jan. 11, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage…

Heron Therapeutics (HRTX) Looks Good: Stock Adds 6.8% in Session

Heron Therapeutics (HRTX) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge…

Heron Therapeutics: Huge Commercial Potential, But Not Out Of The Woods Yet

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Treatment of Postoperative Pain

SAN DIEGO , Nov. 13, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage…

Heron Therapeutics to Present at Several Upcoming Virtual Investor Conferences

SAN DIEGO , Nov. 11, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a…

HERON THERAPEUTICS, INC. /DE/: 10-Q Report

10-Q...…

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

Heron Therapeutics EPS misses by $0.01, beats on revenue

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2020 and Highlights Recent Corporate Updates

SAN DIEGO , Nov. 5, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage…

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

Heron Therapeutics Receives European Commission Authorization for ZYNRELEF™ (HTX-011) for the Treatment of Postoperative Pain

SAN DIEGO , Sept. 28, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a…

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

Heron Therapeutics Announces Publication of Results from EPOCH 2 Follow-On Study, a Phase 2b Study of HTX-011 in Patients Undergoing Hernia Repair Surgery

SAN DIEGO , Sept. 16, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage…

Heron Therapeutics to Present at Cantor Virtual Global Healthcare Conference

SAN DIEGO , Sept. 11, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a…

Heron Therapeutics (HRTX) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

Heron Therapeutics Announces Successful Outcome of FDA Type A Meeting to Discuss HTX-011 for the Management of Postoperative Pain

SAN DIEGO , Sept. 8, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage…

Why Heron Therapeutics Stock Popped in July

Bargain hunters pounced on this beaten-down biotech stock last month. Heres why....…

Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -3.39% and 38.64%, respectively, for the quarter ended June 2020. Do…

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2020 and Highlights Recent Corporate Updates

SAN DIEGO , Aug. 5, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage…

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

Heron Therapeutics Receives Positive CHMP Opinion for ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain

SAN DIEGO , July 24, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a…

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

Heron Therapeutics Announces Initiation of Phase 2 Clinical Study of CINVANTI® for the Treatment of COVID-19

SAN DIEGO , July 16, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a…

Heron Therapeutics readies mid-stage study of aprepitant for COVID-19

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Heron Therapeutics (HRTX) in Focus: Stock Moves 9% Higher

Heron Therapeutics (HRTX) saw a big move last session, as its shares jumped 9% on the day, amid huge volumes....…

Heron Therapeutics: The Play Now

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

Why Pacira BioSciences Is Soaring Today

Thanks to a recent FDA decision, its best-selling product, Exparel, will go at least a little longer without facing competition…

Mid-Day Market Update: Crude Oil Up 1.5%; Heron Therapeutics Shares Plummet

Midway through trading Monday, the Dow traded up 1.78% to 25460.37 while the NASDAQ rose 0.74% to 9829.72. The S&P…

Why Heron Therapeutics Stock Is Tanking Today

Its non-opioid painkiller gets a rejection over non-clinical issues....…

Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain

SAN DIEGO , June 29, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a…

HERON THERAPEUTICS, INC. /DE/: 8-K Report

8-K...…

2 Top Healthcare Stocks to Watch in June

Heron Therapeutics and Novavax are two key healthcare stocks to watch this month....…

Heron Therapeutics Announces Publication of Results from Study 209, a Phase 2b Study of HTX-011 in Patients Undergoing Total Knee Arthroplasty

SAN DIEGO , June 4, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage…

Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2019 and Highlights Recent Corporate Updates

SAN DIEGO , March 2, 2020 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a…